Compound Detail
CHEMBL102651
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL102651 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ALVAPOXOHZKAAJ-GFCCVEGCSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
288.4
MW (Da)
4.24
ALogP
3
HBA
2
HBD
53.6
PSA (Ų)
0.59
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 6.38
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Epidermal growth factor receptor CHEMBL203 | IC50 | 6.38 | 6.38 | 419.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Epidermal growth factor receptor | IC50 | = | 419.0 | nM | 6.38 | Inhibition of EGF-induced Tyrosine phosphorylation in A431 cells expressing EGF-... | 11520212 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 11520212 | 10.1021/jm010888h | Epidermal growth factor receptor | 1 |
Data from ChEMBL 36 via Core Engine